Highlights
- •Flexible endoscopes had residual fluid after reprocessing and drying.
- •Fluid resembled simethicone used to reduce foam and bubbles.
- •Photographs and laboratory analysis found that the fluid contained simethicone.
- •Residual fluid containing simethicone may impact reprocessing effectiveness.
Background
During a study designed to assess endoscope reprocessing effectiveness, a borescope
was used to examine lumens and ports. Cloudy, white, viscous fluid was observed inside
fully reprocessed gastroscopes and colonoscopes. This fluid resembled simethicone,
which is commonly administered to reduce foam and bubbles that impede visualization
during gastrointestinal endoscopy. This article describes methods used to determine
whether the observed fluid contained simethicone.
Methods
Photographs of residual fluid were taken using a borescope. Sterile cotton-tipped
swabs were used to collect samples of fluid observed in 3 endoscope ports. Samples
were evaluated using Fourier transform infrared spectroscopy (FTIR)–attenuated total
reflection analysis.
Results
Residual fluid was observed inside 19 of 20 endoscopes. Fluid photographed in 8 endoscopes
resembled simethicone solutions. FTIR analysis confirmed the presence of simethicone
in 2 endoscopes.
Conclusions
Fluid containing simethicone remained inside endoscopes despite reprocessing. Simethicone
is an inert, hydrophobic substance that may reduce reprocessing effectiveness. Simethicone
solutions commonly contain sugars and thickeners, which may contribute to microbial
growth and biofilm development. Studies are needed to assess the prevalence of residual
moisture and simethicone in endoscopes and determine the impact on reprocessing effectiveness.
We recommend minimizing the use of simethicone pending further research into its safety.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Systematic review and meta-analysis of randomized controlled trials of Simethicone for gastrointestinal endoscopic visibility.Scand J Gastroenterol. 2011; 46: 227-235
- Oral purgative and simethicone before small bowel capsule endoscopy.World J Gastrointest Endosc. 2013; 5: 67-73
- The effect on colon visualization during colonoscopy of the addition of simethicone to polyethylene glycol-electrolyte solution: a randomized single-blind study.Clin Transl Gastroenterol. 2012; 3: e26
- Bowel preparation before colonoscopy.Gastrointest Endosc. 2015; 81: 781-794
- Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy.J Gastroenterol Hepatol. 2014; 29: 769-774
- Premedication with N-acetylcysteine and simethicone improves mucosal visualization during gastroscopy: a randomized, controlled, endoscopist-blinded study.Eur J Gastroenterol Hepatol. 2013; 25: 778-783
- The role of liquid simethicone in enhancing endoscopic visibility prior to esophagogastroduodenoscopy (EGD): a prospective, randomized, double-blinded, placebo-controlled trial.J Med Assoc Thai. 2010; 93: 892-897
- Colonoscopy preparation.Gastrointest Endosc. 2009; 69: 1201-1209
- Implementation of image-enhanced endoscopy into solo and group practices for dysplasia detection in Crohn's disease and ulcerative colitis.Gastrointest Endosc Clin N Am. 2014; 24: 419-425
- Simethicone. Letter to health care practitioner.Olympus, Center Valley (PA)2009
- Practical colonoscopy.John Wiley & Sons, Chichester, West Sussex, UK2013
- Assessing residual contamination and damage inside flexible endoscopes over time.Am J Infect Control. 2016; (In press)
- A review of reported recalls involving microbiological control 2004-2011 with emphasis on FDA considerations of “Objectionable Organisms”.Microbiology. 2012; 15: 42-57
- Simethicone. PubChem open chemistry database.(Available from:) (Accessed September 24, 2015)
- Does the use of simethicone during GI endoscopy pose an increased risk of disease transmission? Discussions in infection control.(Available from:) (Accessed September 25, 2015)
- Instructions for use: Torrent® irrigation tubing.U.S. Endoscopy, Mentor (OH)2014
- Instructions for use: Pentax Video GI Scopes 90i Series 90K Series.Hoya Corporation, Tokyo (Japan)2014
- Correlation between the growth of bacterial biofilm in flexible endoscopes and endoscope reprocessing methods.Am J Infect Control. 2014; 42: 1203-1206
- ANSI/AAMI ST91: 2015, flexible and semi-rigid endoscope processing in health care facilities.Association for the Advancement of Medical Instrumentation, Arlington (VA)2015: 1-70
- Standards of infection prevention in reprocessing flexible gastrointestinal endoscopes.Society of Gastroenterology Nurses and Associates, Inc., Chicago (IL)2015: 1-31
- Gastroscopy-associated transmission of extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa.J Hosp Infect. 2013; 83: 341-343
- Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009.Euro Surveill. 2010; 15: 1-6
- Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography.Endoscopy. 2010; 42: 895-899
- Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.Clin Microbiol Rev. 2013; 26: 231-254
Article Info
Publication History
Published online: August 03, 2016
Footnotes
Funding/Support: Supported by 3M Company , Medivators Incorporated , and HealthMark Industries , which provided study materials and funding for this study. The University of Minnesota Health and Ofstead & Associates, Inc, also provided additional research support.
Disclaimer: The sponsors were not present during endoscope examinations and sample collection, and they did not review this manuscript prior to submission. The physicians and staff at the University of Minnesota received no monetary compensation for participating in the research or writing of this manuscript.
Conflicts of Interest: C.L.O. is employed by Ofstead & Associates, Inc, which has received research funding and speaking honoraria related to infection prevention from STERIS Corporation, 3M Company, Medivators, HealthMark Industries, Boston Scientific, invendo medical, and Advanced Sterilization Products. H.P.W., E.A.J., and O.L.H. are employed by Ofstead & Associates, Inc, and have no other disclosures to report. M.J.S. and T.J.M. have no disclosures to report.
Identification
Copyright
© 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
